{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:28:19Z","timestamp":1794655699560,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFC1001003"],"award-info":[{"award-number":["2017YFC1001003"]}]},{"name":"National Key R&D Program of China","award":["2016YFC1000601"],"award-info":[{"award-number":["2016YFC1000601"]}]},{"name":"National Key R&D Program of China","award":["2016YFC1000201"],"award-info":[{"award-number":["2016YFC1000201"]}]},{"name":"National Key R&D Program of China","award":["2016YFC1000302"],"award-info":[{"award-number":["2016YFC1000302"]}]},{"name":"National Natural Science Funds for general program","award":["81671419"],"award-info":[{"award-number":["81671419"]}]},{"name":"National Natural Science Funds for general program","award":["81571400"],"award-info":[{"award-number":["81571400"]}]},{"name":"National Natural Science Funds for general program","award":["81771580"],"award-info":[{"award-number":["81771580"]}]},{"name":"National Natural Science Funds for general program","award":["81471427"],"award-info":[{"award-number":["81471427"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-018-0950-x","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T09:32:14Z","timestamp":1533807134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["New insights into the genic and metabolic characteristics of induced pluripotent stem cells from polycystic ovary syndrome women"],"prefix":"10.1186","volume":"9","author":[{"given":"Zheying","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-1966","authenticated-orcid":false,"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"issue":"12","key":"950_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223\u201336.","journal-title":"N Engl J Med"},{"issue":"9588","key":"950_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685\u201397.","journal-title":"Lancet"},{"issue":"4","key":"950_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347\u201363.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"950_CR4","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","journal-title":"Hum Reprod"},{"issue":"1\u20132","key":"950_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mrfmmm.2007.11.007","volume":"639","author":"LJ Moran","year":"2008","unstructured":"Moran LJ, Noakes M, Clifton PM, Norman RJ, Fenech MF. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res. 2008;639(1\u20132):55\u201363.","journal-title":"Mutat Res"},{"key":"950_CR6","doi-asserted-by":"publisher","first-page":"6306410","DOI":"10.1155\/2016\/6306410","volume":"2016","author":"AS Lagana","year":"2016","unstructured":"Lagana AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, Granese R, Triolo O. Metabolism and ovarian function in PCOS women: a therapeutic approach with inositols. Int J Endocrinol. 2016;2016:6306410.","journal-title":"Int J Endocrinol"},{"issue":"36","key":"950_CR7","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.2174\/1381612822666160810111528","volume":"22","author":"L Orostica","year":"2016","unstructured":"Orostica L, Rosas C, Plaza-Parrochia F, Astorga I, Gabler F, Garcia V, Romero C, Vega M. Altered steroid metabolism and insulin signaling in PCOS endometria: impact in tissue function. Curr Pharm Des. 2016;22(36):5614\u201324.","journal-title":"Curr Pharm Des"},{"issue":"12","key":"950_CR8","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1017\/S0007114512004369","volume":"109","author":"YH Tsai","year":"2013","unstructured":"Tsai YH, Wang TW, Wei HJ, Hsu CY, Ho HJ, Chen WH, Young R, Liaw CM, Chao JC. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility. Br J Nutr. 2013;109(12):2190\u20138.","journal-title":"Br J Nutr"},{"issue":"16","key":"950_CR9","doi-asserted-by":"publisher","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","volume":"114","author":"ASL Caldwell","year":"2017","unstructured":"Caldwell ASL, Edwards MC, Desai R, Jimenez M, Gilchrist RB, Handelsman DJ, Walters KA. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2017;114(16):E3334\u2013E43.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"950_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/AOG.0b013e31820209bb","volume":"117","author":"ET Wang","year":"2011","unstructured":"Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML, Merkin SS, Schreiner PJ, Sternfeld B, Wellons M, Schwartz SM, Lewis CE, Williams OD, Siscovick DS, Bibbins-Domingo K. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstet Gynecol. 2011;117(1):6\u201313.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"950_CR11","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1210\/jc.2011-0651","volume":"96","author":"VM Victor","year":"2011","unstructured":"Victor VM, Rocha M, Banuls C, Alvarez A, de Pablo C, Sanchez-Serrano M, Gomez M, Hernandez-Mijares A. Induction of oxidative stress and human leukocyte\/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J Clin Endocrinol Metab. 2011;96(10):3115\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"950_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cmet.2009.05.001","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS, Eisenson H, Musante G, Surwit R, Millington DS, Butler MD, Svetkey LPA. Branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance (vol 9, pg 311, 2009). Cell Metab. 2009;9(6):565\u20136.","journal-title":"Cell Metab"},{"issue":"6","key":"950_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cell.2012.02.032","volume":"148","author":"RJ DeBerardinis","year":"2012","unstructured":"DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell. 2012;148(6):1132\u201344.","journal-title":"Cell"},{"key":"950_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, Zhang CM, Wang Y, Liu P, Tu BB, Zhang X, Qiao J. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153.","journal-title":"BMC Med"},{"issue":"8","key":"950_CR15","doi-asserted-by":"publisher","first-page":"e0160571","DOI":"10.1371\/journal.pone.0160571","volume":"11","author":"CS Gobl","year":"2016","unstructured":"Gobl CS, Ott J, Bozkurt L, Feichtinger M, Rehmann V, Cserjan A, Heinisch M, Steinbrecher H, JustKukurova I, Tuskova R, Leutner M, Vytiska-Binstorfer E, Kurz C, Weghofer A, Tura A, Egarter C, Kautzky-Willer A. To assess the association between glucose metabolism and ectopic lipid content in different clinical classifications of PCOS. PLoS One. 2016;11(8):e0160571.","journal-title":"PLoS One"},{"issue":"1","key":"950_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10549-008-9916-5","volume":"113","author":"KN Phoenix","year":"2009","unstructured":"Phoenix KN, Vumbaca F, Claffey KP. Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. 2009;113(1):101\u201311.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"950_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMct0707092","volume":"358","author":"JE Nestler","year":"2008","unstructured":"Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med. 2008;358(1):47\u201354.","journal-title":"N Engl J Med"},{"issue":"3","key":"950_CR18","first-page":"569","volume":"114","author":"V Randriamboavonjy","year":"2015","unstructured":"Randriamboavonjy V, Mann WA, Elgheznawy A, Popp R, Rogowski P, Dornauf I, Drose S, Fleming I. Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity. Thromb Haemost. 2015;114(3):569\u201378.","journal-title":"Thromb Haemost"},{"issue":"3","key":"950_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/humupd\/dmv063","volume":"22","author":"N Naderpoor","year":"2016","unstructured":"Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2016;22(3):408\u20139.","journal-title":"Hum Reprod Update"},{"key":"950_CR20","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1038\/ncomms9464","volume":"6","author":"FR Day","year":"2015","unstructured":"Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, Lawlor DA, Laval G, Mathieson I, McCardle WL, Louwers Y, Meun C, Ring S, Scott RA, Sulem P, Uitterlinden AG, Wareham NJ, Thorsteinsdottir U, Welt C, Stefansson K, Laven JS, Ong KK, Perry JR. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464.","journal-title":"Nat Commun"},{"key":"950_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bpobgyn.2016.04.002","volume":"37","author":"H Zhao","year":"2016","unstructured":"Zhao H, Lv Y, Li L, Chen ZJ. Genetic studies on polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2016;37:56\u201365.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"8","key":"950_CR22","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1210\/en.2014-1196","volume":"155","author":"AS Caldwell","year":"2014","unstructured":"Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, Handelsman DJ, Walters KA. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146\u201359.","journal-title":"Endocrinology"},{"issue":"34","key":"950_CR23","doi-asserted-by":"publisher","first-page":"E7187","DOI":"10.1073\/pnas.1708854114","volume":"114","author":"A Benrick","year":"2017","unstructured":"Benrick A, Chanclon B, Micallef P, Wu Y, Hadi L, Shelton JM, Stener-Victorin E, Wernstedt Asterholm I. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proc Natl Acad Sci U S A. 2017;114(34):E7187\u2013E96.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37","key":"950_CR24","doi-asserted-by":"publisher","first-page":"15768","DOI":"10.1073\/pnas.0906894106","volume":"106","author":"R Maehr","year":"2009","unstructured":"Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009;106(37):15768\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"950_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.18632\/aging.100428","volume":"4","author":"S Ohmine","year":"2012","unstructured":"Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012;4(1):60\u201373.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"950_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","volume":"143","author":"MCN Marchetto","year":"2010","unstructured":"Marchetto MCN, Carromeu C, Acab A, Yu D, Yeo GW, Mu YL, Chen G, Gage FH, Muotri AR. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell. 2010;143(4):527\u201339.","journal-title":"Cell"},{"issue":"7227","key":"950_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2009","unstructured":"Ebert AD, Yu JY, Rose FF, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457(7227):277\u2013U1.","journal-title":"Nature"},{"issue":"4","key":"950_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"3","key":"950_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.fertnstert.2005.09.017","volume":"85","author":"TA Santos","year":"2006","unstructured":"Santos TA, El Shourbagy S, St John JC. Mitochondrial content reflects oocyte variability and fertilization outcome. Fertil Steril. 2006;85(3):584\u201391.","journal-title":"Fertil Steril"},{"issue":"2","key":"950_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/EJE-09-0733","volume":"162","author":"E Diamanti-Kandarakis","year":"2010","unstructured":"Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol. 2010;162(2):193\u2013212.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"950_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/MED.0000000000000245","volume":"23","author":"KA Walters","year":"2016","unstructured":"Walters KA. Androgens in polycystic ovary syndrome: lessons from experimental models. Curr Opin Endocrinol Diabetes Obes. 2016;23(3):257\u201363.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"950_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/humrep\/dex036","volume":"32","author":"DH Abbott","year":"2017","unstructured":"Abbott DH, Rayome BH, Dumesic DA, Lewis KC, Edwards AK, Wallen K, Wilson ME, Appt SE, Levine JE. Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys. Hum Reprod. 2017;32(4):923\u201336.","journal-title":"Hum Reprod"},{"key":"950_CR33","doi-asserted-by":"crossref","unstructured":"Park ES, Lind AK, Dahm-K\u00e4hler P, Br\u00e4nnstr\u00f6m M, Carletti MZ, Christenson LK, Curry TE Jr, Jo M. RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries. Mol Endocrinol. 2010;24(4):846\u201358.","DOI":"10.1210\/me.2009-0392"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-0950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-018-0950-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-018-0950-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:09:15Z","timestamp":1565291355000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-018-0950-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1186\/s13287-018-0950-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Institutional Review Board and Ethics Committee of Peking University Third Hospital. Written informed consent was obtained from all patients enrolled in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"210"}}